Apyx Medical (APYX) Profit After Tax (2010 - 2026)

Apyx Medical has reported Profit After Tax for 17 years, with the latest figure at -$2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax rose 49.47% year-over-year to -$2.1 million; the trailing twelve-month figure through Mar 2026 stood at -$9.1 million (up 54.75% YoY), and the FY2025 full-year result was -$11.1 million, up 52.67% from the prior year.
• Profit After Tax for Q1 2026 stood at -$2.1 million, down from -$1.2 million in the prior quarter.
• The five-year high for Profit After Tax was -$1.0 million in Q2 2023, with the low at -$9.6 million in Q4 2023.
• Historically, Profit After Tax has averaged -$4.6 million across 5 years, with a median of -$4.7 million in 2023.
• Annual changes were most pronounced in 2023 — Profit After Tax jumped 81.22% — and 2024, when it sank 546.32%.
• Apyx Medical's Profit After Tax stood at -$6.0 million in 2022, then plunged by 61.18% to -$9.6 million in 2023, then soared by 52.59% to -$4.6 million in 2024, then surged by 72.82% to -$1.2 million in 2025, then slumped by 70.0% to -$2.1 million in 2026.
• The last three Profit After Tax figures came in at -$2.1 million (Q1 2026), -$1.2 million (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.